<span id="midArticle_start"/> Medical Prognosis Institute A/S :
<span id="midArticle_0"/>* Medical Prognosis Institute and Nemucore announcestrategic partnership
<span id="midArticle_1"/> <span class="first-article-divide"/>* Medical Prognosis Institute A/S and Nemucore MedicalInnovations, Inc. announced partnership to advance the clinicaldevelopment of an undisclosed oncology therapeutic by employinga Drug Response Predictor (DRP(TM)) Biomarker to identify cancerpatients likely to respond to the drug for the treatment ofcertain cancersSource text for Eikon:
<span id="midArticle_2"/> <span class="second-article-divide"/> <span class="third-article-divide"/>Further company coverage: (Gdynia Newsroom)
<span id="midArticle_3"/>
<span id="midArticle_0"/>* Medical Prognosis Institute and Nemucore announcestrategic partnership
<span id="midArticle_1"/> <span class="first-article-divide"/>* Medical Prognosis Institute A/S and Nemucore MedicalInnovations, Inc. announced partnership to advance the clinicaldevelopment of an undisclosed oncology therapeutic by employinga Drug Response Predictor (DRP(TM)) Biomarker to identify cancerpatients likely to respond to the drug for the treatment ofcertain cancersSource text for Eikon:
<span id="midArticle_2"/> <span class="second-article-divide"/> <span class="third-article-divide"/>Further company coverage: (Gdynia Newsroom)
<span id="midArticle_3"/>
via Smart Health Shop Forum http://ift.tt/1AESMHv
No comments:
Post a Comment